Biolife Solutions (BLFS) Operating Leases (2019 - 2026)

Biolife Solutions (BLFS) has 8 years of Operating Leases data on file, last reported at $12.4 million in Q1 2026.

• Quarterly Operating Leases fell 11.73% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (down 11.73% YoY) and the FY2025 annual result came in at $10.7 million, down 15.72% from the prior year.
• Operating Leases rose to $12.4 million in Q1 2026 per BLFS's latest filing, from $10.7 million in the prior quarter.
• Across five years, Operating Leases topped out at $18.7 million in Q1 2022 and bottomed at $8.7 million in Q4 2023.
• The 5-year median for Operating Leases is $14.0 million (2025), against an average of $14.2 million.
• The widest annual swing landed in 2022, when Operating Leases jumped 101.23%; it then plunged 41.89% in 2023.
• Tracing BLFS's Operating Leases over 5 years: stood at $15.0 million in 2022, then tumbled by 41.89% to $8.7 million in 2023, then jumped by 45.43% to $12.6 million in 2024, then fell by 15.72% to $10.7 million in 2025, then climbed by 15.96% to $12.4 million in 2026.
• Per Business Quant, the three latest BLFS Operating Leases figures stand at $12.4 million (Q1 2026), $10.7 million (Q4 2025), and $13.2 million (Q3 2025).

Peer Comparison